Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 263.09% | 181.59% | 65.40% | 50.89% | 54.79% |
| Total Depreciation and Amortization | 93.68% | 26.03% | -33.17% | -38.62% | -40.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -607.82% | -374.03% | -58.39% | -10.73% | -24.64% |
| Change in Net Operating Assets | -69.88% | 154.96% | -175.94% | 180.12% | 20.66% |
| Cash from Operations | -1,841.80% | -319.94% | 108.97% | 141.19% | 92.21% |
| Capital Expenditure | 55.17% | 27.12% | 46.36% | -924.92% | -922.05% |
| Sale of Property, Plant, and Equipment | -- | -50.00% | -50.00% | -96.38% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 348.06% | 445.66% | 180.79% | 12.03% | 74.11% |
| Cash from Investing | 6,965.16% | 1,227.94% | 761.04% | -120.38% | -105.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.93% | 52.50% | -8.53% | 17.76% | 124.29% |
| Repurchase of Common Stock | -75.60% | -765.61% | -614.56% | -9,168.63% | -3,451.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.75% | -478.83% | -744.29% | -201,280.00% | -7,477.63% |
| Foreign Exchange rate Adjustments | -138.73% | -2,388.89% | 241.18% | 110.53% | -115.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.59% | 109.54% | 389.76% | 58.81% | 39.14% |